Search results

• 2021

  Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis

  Andres Ejarque, R., Ale, H. B. A., Grys, K., Tosi, I., Solanky, S., Ainali, C., Catak, Z., Sreeneebus, H., Saklatvala, J., Dand, N., de Rinaldis, E., Chapman, A., Nestle, F., Barnes, M. R., Richard, W., Reynolds, N. J., Griffiths, C., Barker, J., Smith, C., Di Meglio, P., & 1 othersCOnsortium, PSORT., Dec 2021, In: Nature Communications. 12, 1, p. 4741 1 p., 4741.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Dendritic Cell 100%
  • Adalimumab 100%
  • Mediator 50%
  • Phosphorylation 50%
  • Tumor Necrosis Factor 50%
  10 Citations (Scopus)

  60 Downloads (Pure)